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Objective: To describe the features of community-acquired Escherichia coli pneumonia and to compare these patients 
with patients with pneumonia caused by other etiologic agents. 
Patients and Methods: This prospective study was carried out at five medical institutions in three geographic 
locations-Pittsburgh, PA, Boston, MA and Halifax, NS. Pneumonia etiology was assigned, based on results of 
microbiological investigations, by a committee consisting of five investigators using rules established prior to the study. 
Demographic and clinical features and outcomes of patients with E. coli pneumonia were compared with those of 
pneumonia due to other microorganisms. 
Results: Nineteen patients (9 (47.4%) blood culture positive) had pneumonia due to E. coliand 430 (69 (16.0%) blood 
culture positive) had pneumonia caused by other etiologic agents. E. coli was the second most common cause of 
bacteremic pneumonia. The E. colipatients were older, and more likely to be female, from a nursing home and confused 
compared with patients with pneumonia due to other microbial agents. They were more severely ill as measured by a 
validated pneumonia specific severity of illness scoring measure. 
Although there was no in-hospital mortality for the patients with E. colipneumonia, the 90-day mortality was 21%. Thirty- 
two (7.4%) of the patients with pneumonia due to other agents died in hospital and the 90-day mortality rate was 13.5% 
( p  NS). Eight of the 19 patients with E. coli pneumonia were admitted from a nursing home and an additional four 
patients (63.2%) were discharged to such a facility. In contrast, only 44 (10.2%) of the patients with pneumonia due to 
other agents were discharged to a nursing home (p<O.OOl). 
Conclusions: Patients diagnosed with E. coli pneumonia are frequently bacteremic. They are older than patients with 
pneumonia due to other etiologies, and more likely to be female, from a nursing home and severely ill. Despite the 
absence of in-hospital mortality, 21% of these patients died within 90 days of presentation. 
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INTRODUCTION 
Pneumonia caused by aerobic Gram-negative bacilli 
(AGNB) was recognized with increasing frequency 
during the 1960s and 1970s [1,2]. Tillotson and Lerner 
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[l] noted that AGNB accounted for 4.3% of all 
pneumonias seen at the Detroit Receiving Hospital 
from July 1963 to December 1965. Sixty-four of the 
82 cases (78%) were community-acquired. Klebsiella- 
Enterobacter was most common among the community 
acquired cases, accounting for 20 of the 64 cases, 
followed by 15 cases of Escherichia coli pneumonia. 
Pierce and Sanford [2] reviewed nine studies of 
pneumonia carried out from 1949 to 1970 and noted 
that AGNB caused 5.7% of the cases during 1949-50 
and 12.6% during 1969-1970. Through the 1980s and 
1990s, AGNB have become the leading cause of 
nosocomial pneumonia [3], but very little attention 
has been paid to these microorganisms as a cause of 
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community-acquired pneumonia (CAP). Indeed, when 
Fine et a1 [4] reviewed 127 study cohorts of patients 
with CAP reported between 1966 and 1995, only 
91 of 18 292 (0.5%) patients had pneumonia due to 
AGNB. Seventeen of these patients had pneumonia 
due to Errhericlzia coli [4]. In this paper we compare the 
features of CAP presunied to be caused by Errhericlzia 
coli with those of pneumonia due to other microbial 
agents. 
MATERIALS AND METHODS 
Patients who were hospitalized for treatment of 
CAP in the Pneumonia Patient Outcomes Research 
Team (PORT) cohort rtudy were managed at four 
medical institutions in three geographic locations: The 
University of Pittsburgh Medical Center (UPMC), a 
942-bed university teaching hospital, and St Francis 
Medical Centre (SFMC), a 427-bed comniunity teach- 
ing hospital, in Pittsburgh, PA; The Massachusetts 
General Hospital (MGH), an 899-bed university teach- 
ing hospital, in Boston, MA; and the Victoria General 
Hospital (VGH), a 637-bed university teaching hospital, 
in Halifax, Nova Scotia, Canada. In addition, patients 
who did not require hospitalization for treatment 
of CAP were recruited from the above institutions 
and from Harvard Community Health Plan-Kenmor 
(HCHP), a clinical site with 44 931 members within a 
staff-model health maintenance organization, in Boston, 
MA. 
The pneumonia PORT cohort study included 
both patients with CAP who were treated at home 
(outpatients) and those who were admitted to hospital 
(inpatients) for treatment of their pneumonia. Potential 
study subjects were identified by screening patients, 
admitted to the participating institutions by trained 
nurse researchers, through daily review of emergency 
and radiology department records. Study inclusion 
criteria were: (1) age 218 years; (2) acute onset of one 
or more clinical symptonis suggestive of pneunionia 
within 24 h of presentation; (3) acute radiographic 
evidence of pneumonia within 24 h of presentation 
determined by a study site radiologist; and (4) provision 
of informed consent by the patient or patient proxy. 
Patients were ineligible for the study if they were 
discharged from the hospital within the 10 days pre- 
ceding presentation, were known to be HIV positive, 
or were previously enrolled in the cohort study. 
Patient data collection 
Following patient enrollment, trained research nurses 
systematically collected information from the time of 
presentation and during the clinical course of the ill- 
ness. Demographic data included age, gender, ethnicity, 
occupation, eniployment status, insurance coverage, 
and marital status. The presence or absence of five 
respiratory symptoms (cough, dyspnea, sputum pro- 
duction, pleuritic chest pain, and hemopytsis) and 14 
non-respiratory symptoms, including fatigue, fever, 
chills, sweats, confusion, nausea, vomiting, abdominal 
pain, myalgia, anorexia, weight loss, and inability to eat, 
were recorded. The presence of the above symptoms 
and the following co-morbid conditions was deter- 
mined by patient report (or by interview with care- 
givers to determine the need for a proxy respondent). 
A 1 0-item mental status questionnaire (age, birthplace, 
current date, patient’s street address, name of hospital, 
name of city current president or prime minister, past 
president or prime minister) was administered and 
for scores of 3 or less a proxy respondent was ?ought. 
A proxy respondent was also sought for patients who 
were confused or who had language barriers, together 
with a review of medical records: history of cigarette 
smohng, pulmonary disease (asthma, chronic obstructive 
pulmonary disease, or interstitial lung disease), cardio- 
vascular disease (ischemic heart disease or congestive 
heart failure), cancer, diabetes mellitus, and cerebro- 
vascular disease. Baseline physical examination findings, 
including heart rate, temperature, blood pressure, and 
respiratory rate, were obtained from the medical record. 
Confusion was also included as a sign. At time of 
interview, patients were classified as alert, lethargic, 
stuporous or comatose. Medical records were reviewed 
and next of kin were interviewed to ascertain if 
confusion or mental status was a change from baseline. 
In addition, if the medical record and relatives did 
not record dementia prior to presentation, did the 
patient ever have an impaired mental status defined by 
the following: physician-documented dementia, or 
Alzheimer’s disease, or organic brain syndrome or 
senility? The baseline laboratory data (if obtained) 
recorded included complete blood counts, electrolytes, 
seruni glucose, liver function tests and arterial blood 
gases. Results of microbiological testing (obtained at 
the discretion of the attending physician) were recorded 
(sputum Gram stain and culture, blood cultures, pleural 
fluid cultures, serologic tests). 
Antibiotic therapy 
Antibiotics used to treat the pJtients were grouped 
into classes as follows: macrolides (erythromycin, 
clarithromycin and azithromycin), aminopenicillins 
(amoxycillin-clavulanate, ampicillin, ampicillin- 
sulbactani, amoxycillin), first-generation cephalosporins 
(cephalothin, cefazolin, cephalexin), second-genera- 
tion cephalosporins (cefuroxinie, cefotetan), third- 
generation cephalosporins (ceftazidinie, cefotaxime, 
ceftizoxinie, ceftriaxone), natural penicillins (penicillin, 
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phenoxymethyl penicdlin) , extended-spectrum peni- 
cillins (ticarcillin, piperacillin, ticarcillin-clavulanate, 
azlocillin, mezlocillin), aminoglycosides (gentamicin, 
tobramycin), and fluroquinolones (ciprofloxacin) . 
Review of chest radiographs 
Copies of all chest radiographs obtained at the time 
of clinical presentation were sent to Pittsburgh and 
independently reviewed by a panel of staff radiologists 
at the University of Pittsburgh who were blinded to 
clinical data. Definitions of various radiographic findings 
were as previously described [ 5 ] .  For all films of 
adequate quality, an initial evaluation was made to 
confirm the presence of a radiographic infiltrate. For all 
films indicative of pneumonia (i.e. ‘possible’, ‘probable’ 
or ‘definite’ infiltrate) based on the majority opinion 
of three radiologists, a standardized data form was 
completed by one panel member which included 
information on the radiographic pattern of the infdtrate 
(i.e. alveolar, interstitial, or mixed), number of lobes 
involved, and presence of pleural effusion. 
Microbiological methods and assignment of etiology of 
pneumonia 
Sputum Gram stain, culture, identification and report- 
ing of microorganisms were carried out in accordance 
with pre-existing protocols at each study site. These 
procedures were carried out as part of the routine 
diagnostic services of each institution’s microbiology 
laboratory. 
For the purposes of this study, microbiological 
etiology was assigned by a committee consisting of five 
investigators in the pneumonia PORT cohort study 
(MF, DS, WK, CC, TM). Two investigators reviewed 
data on each patient and used rules established prior to 
the study to assign etiology. If there was disagreement 
as to the etiology, the case was presented to the entire 
committee, where a majority decision ruled. All 
pathogens isolated from blood cultures were judged to 
be the definite cause of the pneumonia. In addition, if 
Legionella pneumophila or Mycobacterium tuberculosis were 
isolated from sputum or if Pneumocystis carinii cysts or 
trophozoites were seen by stain, these agents were 
classified as definite causes of pneumonia. A four-fold 
rise in antibody titer between acute- and convalescent- 
phase serum samples to Mycoplasma pneumoniae, Legionella 
pneumophila, influenza viruses A and B, parainfluenza 
1,2 and 3 and respiratory syncytial virus was indicative 
that this agent was the definite cause of the pneumonia. 
Isolates from sputum were categorized as the pre- 
sumptive cause of the pneumonia [6] if: 
There was heavy or moderate growth of a pre- 
dominant bacterial pathogen. 
There was light growth of a pathogen in which the 
sputum Gram stain revealed a bacterium compatible 
with the culture results. 
The same genus and species of a bacterium was 
isolated from multiple sputum cultures obtained 
within 3 days of admission. 
0 In the case of multiple potential bacterial pathogens 
growing in equal magnitude, there was a pre- 
dominant organism seen on Gram stain that was 
compatible with one of these isolates. If Gram stain 
revealed the presence of multiple organisms con- 
sistent with those isolated on culture, then multiple 
pathogens were considered to be responsible. 
Aspiration pneumonia was diagnosed in patients with a 
disorder known to alter consciousness, the normal gag 
reflex, or swallowing mechanisms, or in whom the 
chest radiograph revealed an opacity involving the 
superior or basilar segments of the lower lobes or the 
posterior segments of the upper lobes. Post-obstructive 
pneumonia was diagnosed radiographically or broncho- 
scopically in the presence of a pulmonary infiltrate 
located distal to an obstructing neoplasm. 
Pneumonia-specific severity of illness measure 
Patients were stratified into five risk classes based on a 
previously validated pneumonia prediction rule for 
prognosis [7]. This prediction rule accurately classifies 
patient risk of 30-day mortality and other adverse 
outcomes based on three demographic features (age, 
gender, nursing home residence), five co-morbid 
illnesses, five physical examination abnormalities (four 
vital signs and mental status) and seven laboratory and 
radiographic findings at presentation. AU-cause mortality 
at 30 days ranged from 0.1% (class I) to over 27% (class 
V) . 
Outcomes 
In-hospital 30- and 90-day mortality, and medical 
complications during hospital stay, were recorded. 
A committee consisting of TM,  MF, CC, DS and 
WK determined the underlying cause of death, the 
immediate cause of death and whether pneumonia was 
a major or minor contributor to the cause of death, 
using the following definitions. The underlying cause 
of death was defined as the disease or injury which 
initiated the train of morbid events leading directly to 
death. The immediate cause of death was defined as the 
disease, injury or complication immediately preceding 
death [8]. If pneumonia was not the underlying or 
immediate cause of death, the investigators evaluated 
whether it was a major or minor contributing cause of 
mortality. Pneumonia was considered to be a major 
contribution if death would not have occurred if the 
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patient did not have pneumonia, but another 
condition, potentially lethal, was present and also 
contributed. It was considered to be a minor con- 
tribution if it was not essential to explain death but 
played a role. 
Data analysis 
The chi-square statistic was used to test for differences 
in proportions among categorical variables. Analysis of 
variance and Student's t-test were used for continuous 
variables. To account for the skew in length of hospital 
stay, statistical comparisons were made following log 
transformation. A two-tailed p-value of 10.05 was 
considered to be statistically significant. 
The Pneumonia PORT study population consisted of 
2287 patients, 944 (41.3%) of whom were treated on 
an ambulatory basis and 1343 (58.7%)) of whom were 
hospitalized. Eleven per cent of the outpatients and 
58% of the inpatients had a sputum culture performed 
within 48 h of presentation. Just over 2% of the 
outpatients and 71% of the inpatients had blood 
cultures performed. An etiologic diagnosis was made in 
52 of 907 (5.7%) outpatients and in 396 of 1339 
(29.5%)) inpatients. Escherichiu coli was assigned as the 
etiologic agent in 19 patients (all of whom required 
hospitalization). This agent, which accounted for 1.4% 
of the pneumonias among inpatients and 0.8% overall, 
was the fourth most commonly identified agent (among 
all 2287 study patients) after Streptococcus pneutnoniur 
(n1138; 6.0%), Hemophilrrr inpuenzue (n=78: 3.4%) 
and Staphylococcus aii~eus ( ~ 2 9 ;  1.2%). Nine of the 19 
(47.4%) patients with Esrliericlzia coli pneumonia had the 
diagnosis made on the basis of a positive blood culture. 
This compares with 42.7% for the 138 patients with 
Streptococcus pneumoniue, six of 29 (20.7%) for Stuphylo- 
coccus uurrus and one of 12 (8.3%)) for Pseirdomonur 
neruginoru. Among the entire study cohort there were 
Table 1 Demographic features of 19 patients with pneumonia due to Erclwricliin coli compared with 430 patients with 
pneumonia due to other microorganisms 
~~~ ~~ 
Ocherichia coli Other causes 1' 
No. 19 430 
Mean age + SU" (years) 77211 61219 < ( I  001 
No. (%) males 6 (31..5) 244 (56.7) lI.ms 
No. (%I) bactercnnr 9 (47.4) 91 (21.7) ~11.001 
No. (94) enrolled at :  
Pittsburgh 4(21.1) 113 (26.3) 
Boston 9 (47.4) 226 (52.6) 11.58 
Halifax 6 (31.6) 91 (21.2) 
No. (%) froin a nurwig honie 8 (42.1) 42 (9.8) <0.001 
N o  ("At) outpatients 0 i 2  (12.1) 11.1.5 
No. (%) in risk c l a s  171 
I 0 (0.0) 80 (18.6) 
J J  1 (5.3) 69 (16.1) 
111 2 (1O.i) 88 (20.5) 
IV 7 (36.8) 118 (29.8) 
V 9 (47.4) h i  (15.1) <II .OOl 
No co-morbidity 3 (15 8) 90 (20.9) lI.7X 
Alcoholisni 2 (10.5) 60 (14.2) 1 00 
Mhgiiancy 7 (36.8) 76 (17.7) ( I  116 
Iiiimtinosuppressio~i 4(21.1) Si (12 8) I I  30 
Ilctiicntia 5 (26.3) 24 (5.0) lI,l1l15 
Current intravenouy drus ust- 0 (0.ll) 9 (2.1) I.Il0 
1 hbetes  mellitus 2 (10.5) 55 (12.8) 1.00 
A\piration 4 (21.1) 32 (7.5) il.06 
No. ('51) wi th :  
Neuromuscular or iiiusculo~kelctal disorder" 5 (26.3) 46 ( 1 0  7) i I . l l5 
"SD, standard deviation 
"Neuroniuscular disease was &fined as one o r  inore of the following: aiiivotrophic lateral sclcrosi,. my.i\thenia gr'ivis, multiple sclcro\ir, 
kyphoscoliosis, Parkinson's disease, paraplegia, quadriplegia, rheumatoid arthritis. 
' Jrniiiunosuppre~~ion was defincd as one or iiiore of the following: white blood cell < 3Ol)(l/iiini ', asp1eni.i. l iy~~op-arnn~aglobul~ncmi~~. use of 
inyelosuppressive d r u g  within 90 days of presentation. use of systemic corticosterotds (2 10 mg/dav of pi-ediiisone or Its equivalent), or solid 
organ transplantation. 
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79 patients who were bacteremic, with Streptococcus 
pneumoniae accounting for 74.6% (59/79) and Escherichia 
coli for 11.3% (9/79). 
Four hundred and seventy-eight of the 1339 
(35.7%) (data not available for four inpatients) in- 
patients had 633 sputum specimens processed for 
culture on the day of presentation. Escherichia coli was 
isolated from 16 of the 633 specimens (2.5%) obtained 
on the day of presentation, and from 28 of 920 (3.0%) 
sputum specimens processed within 48 h of admission. 
Ten of the 28 isolates (each of the isolates was obtained 
from a different patient) (35.7%) fit our criteria for a 
presumptive etiologic agent. Three of the 10 patients 
with Escherichia coli pneumonia who had this diagnosis 
made on the basis of sputum culture also had other 
microorganisms isolated from the sputum. These in- 
cluded Staphylococcus aureus from two patients and 
Enterobacter cloacae from one patient. We compared the 
nine bacteremic Escherichia coli pneumonia cases with 
those who had Escherichia coli only isolated from sputum 
and those with Escherichia coli and other micro- 
organisms. There were no differences among the groups 
(however, the small numbers in each group render 
meaningful comparison impossible), so only data for 
the entire group are presented. 
Table 1 shows that the patients with presumed 
Escherichia coli pneumonia differed from those with 
pneumonia attributed to other etiologic agents. The 
Escherichia coli patients were older, and more likely to 
be female, bacteremic, reside in a nursing home, have 
altered mental status on admission and a prior diagnosis 
of dementia. They were also more likely to be more 
seriously ill, with 84.2% falling into risk classes IV 
and V compared with 44.9% for other etiologies 
@<0.001). The Escherichia coli patients were less likely 
to complain of cough-42% versus 83% for patients 
with pneumonia due to other etiologies (Table 2). 
They were more likely to be confused (73% versus 
31.6%) and more likely to be afebrile (57.8% versus 
28.8%) (p=0.006) (Table 2). 
The patients with Escherichia coli pneumonia had a 
significantly (p=0.01), lower mean hemoglobin con- 
centration (1 17 k 18 g/L) than patients with pneumonia 
due to other causes (129 k 2 1  g/L). Other laboratory 
parameters, including white blood cell count, platelet 
count, serum creatinine, serum glucose, pOz and p C 0 ~  
values, did not differ significantly between the two 
groups. 
Despite the finding that almost half of these 
Escherichia coli pneumonia patients fell into risk class V, 
there was no in-hospital mortality. The 90-day mor- 
tality was 21%, which was not significantly different 
(p=0.32) from 13.5% for the 430 patients with 
pneumonia caused by other etiologic agents. Pneumonia 
Table 2 Clinical features of 19 patients with pneumonia 
due to Escherichia coli compared with 430 patients with 
pneumonia due to other etiologic agents 
Feature 
~- 
Escherichia 
coli (19) Other (430) p 
Symptoms 
No. ("A) with: 
Cough 8 (42.1) 
Sore throat 6 (31.5) 
Shortness of breath 12 (63.2) 
Chest pain 6 (31.5) 
Fatigue 16 (84.2) 
Chills 10 (52.6) 
Sweats 8 (42.1) 
Confusion 14 (73.7) 
Nausea 6 (31.5) 
Vomiting 5 (26.3) 
Diarrhea 5 (26.3) 
Anorexia 13 (68.4) 
Weight loss past 6 months 6 (31.5) 
Sputum production 9 (47.3) 
Fever 9 (47.3) 
Headache 2 (10.5) 
Abdominal pain 4 (21.1) 
Hemopytsis 2 (10.5) 
Signs 
Mean temperature ("C) 
No. (%) with temperature: 
(-C SD) 37.22 1.4 
537°C 11 (57.8) 
238°C 5 (26.3) 
Mean pulse rate (2SD) 103216 
Mean respiratory rate 
(?SD) 26?6 
357 (83.0) 
303 (70.4) 
112 (26.1) 
313 (72.7) 
384 (89.3) 
306 (71.1) 
294 (68.3) 
262 (60.9) 
136 (31.6) 
189 (43.9) 
169 (39.3) 
118 (27.4) 
108 (25.1) 
91 (21.6) 
298 (69.3) 
151 (35.1) 
78 (18.1) 
191 (44.4) 
37.721.3 
124 (28.8) 
179 (41.6) 
103221 
26*8 
<0.001 
0.11 
0.38 
0.29 
0.36 
1 .OO 
0.05 
0.17 
0.16 
<0.001 
0.006 
0.91 
1 .00 
0.78 
1 .00 
0.57 
0.77 
0.75 
0.10 
0.006 
0.18 
0.94 
0.88 
was a major cause of death in one of the four (25%) 
patients with Eschevichia coli pneumonia who died 
within 90 days of presentation versus 34 of 70 (48%) 
for patients with pneumonia due to other etiologic 
agents. Only four (21%) of the Escherichia coli pneu- 
monia patients were discharged to home. Eight patients 
(42%) with Escherichia coli pneumonia were admitted 
from a nursing home and an additional four were 
discharged to such a facility (Table 3). In contrast, only 
9.8% of the patients with pneumonia due to other 
causes were admitted from a nursing home (p<0.001). 
The Eschevichia coli patients had a longer mean and 
median length of stay than did the patients with 
pneumonia due to other agents (Table 3). 
Eight (42.2%) Escherichia coli patients had multilobe 
pneumonia and 15.8% had a pleural effusion on 
admission. The right lower lobe was most commonly 
involved-12 (63%); left lower lobe eight (42%); in 17 
(89.5%) the opacities were bronchopneumonic and 
in two (10.5%) they were lobar. These findings did 
not differ significantly from the radiographic findings 
for the 430 patients with pneumonia due to other 
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Table 3 Outcomes of 19 patients with Escherichia coli pneumonia compared with 430 patients with pneumonia due to other 
c a u m  
Other P Feature Escherichia coli 
No (%) admitted to intensive care unit’ 
Mean length of stay (days) (2 SD)b 
Median length of stay (dayr)” 
No. (“A) died in hospital” 
No. (96) died within 90 dayr of presentation with pneumonia 
No. (%I) in which pneunionia was the major cause of death 
No. (?4) diccharged to: 
H o n ~ c ~  
Nursing home,’ 
No. (“A) with any complication 
No. (“A]) with no complications 
No. (%) with: 
Respiratory failure 
Congestive heart failure 
Shock 
Anemia 
Throiiibocytopenia 
Renal insufficiency 
I>erniatiti\ 
Nosocomial pneumonid 
2 (10.5) 
lh .3+11.9  
12 
1) 
4 (21.1) 
1 (5.3) 
4 (21.1) 
14 (73.7) 
.5 (26.3) 
7 (36.8) 
4 (21.1) 
4 (21.1) 
4 (21.1) 
2 (10.5) 
12 (63.1) 
i (26.3) 
2 (10.5) 
0 (0.0) 
70 (18.5) 
1 1  .9-t 15.9 
8 
32 (7.4) 
34 (7.4) 
58 (13.j) 
276 (73.8) 
282 (65.6) 
44 (11.8) 
148 (34.4) 
167 (38.8) 
64 (14.9) 
51 (11.9) 
62 (14.4) 
70 (16.3) 
29 (6.7) 
34  (7.0) 
7 (1.6) 
0% 
0.013 
O.Oll1 
0.30 
0.32 
1 .oo 
< 0.00 1 
< 0.01 i 1 
0.47 
0.47 
0.80 
0.53 
1). 19 
0.27 
0.38 
0.50 
0.66 
I . ( J  
‘Thcw items were examined for inpatients only 
“t-tcst log ccalc. 
etiologies. One patient with E.icherichia coli pneumonia 
did have empyema. Esrherichia coli was isolated from the 
empyema fluid. 
There were no differences in the types of coni- 
plications suffered by both groups (Table 3). Most 
(73.7%) of the patients with Eschericlzia coli pneumonia 
were treated with an aminoglycoside, compared with 
31.6% for the other patients (p<O.OOI) .  The patients 
with Esrherichia coli pneumonia were also more likely to 
be treated with a first-generation cephalosporin (42.1% 
versus 11.6%) (p<O.O01). In all instances, initial anti- 
biotic therapy was effective against Escherichia coli for 
the 19 patients with this diagnosis. 
Five of the nine Escherichia coli bacteremic patients 
had received antibiotics prior to admission, while only 
one of 10 with Escherichia roli in the sputum had 
received antibiotics prior to admission. 
DISCUSSION 
I n  this study we found that Eschrrichia coli accounted for 
a small percentage of cases of CAP; however, it was the 
second most common cause of bacterenlic pneumonia. 
Our data are similar to those of Marston et a1 [9]. These 
workers studied 2776 patients with CAP requiring 
hospitalization in Franklin and Summit Counties, Ohio 
during 1992. Esc-herichia coli caused 1.2% of the 
pneunionias overall (1.6% for the inpatients in our 
study) and it was second only to Streptococcus pneumoriiae 
as a cause of bactereniic pneumonia. In Tillotson and 
Lerner’s study [l], reported in 1967, 15 of 20 patients 
with Escherichia coli pneumonia had community- 
acquired disease. It is difficult to directly compare our 
data with those of Tillotson and Lerner, since their 
patients with nosocomial infection were not separated 
from those with community-acquired infection. Never- 
theless, bacteremia was common in both reports; 8 of 
18 (44%) in Tillotson’s study versus 47%) in our study. 
The in-hospital mortality rate in Tillotson’s study was 
49%, compared with none in our study. The most likely 
reason for this difference in mortality is the current 
approach to the empirical treatment of CAP. All of our 
patients received initial antibiotic therapy effective 
against Escherichiu coli. At Halifax, most patients received 
erythromycin and cefuroxime, while ampicillin- 
sulbactam or cefuroxime plus erythromycin was used in 
Pittsburgh. At the Boston site, 38.7% of the patients 
received gentarnicin at the time of admission [lo]. In 
contrast, only two of the 12 fatal cases in Tillotson’s 
study ever received antibiotics with in vitro activity 
against E-dterichia coli [ 1 I .  The other major difference 
was that eight (40%) of Tillotson’s patients developed 
einpyema, compared with one of our patients [l]. 
Our study does highlight how patient5 with 
Escherichia coli pneumonia differ from those with 
pneumonia due to other causes-they were older, and 
more likely to be from a nursing home and be coil- 
fused, and almost half of them were severely ill. They 
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were less likely to complain of cough and anorexia. 
Only 28% were discharged home. While there was no 
in-hospital mortality, the 90-day mortality rate was 
21%. The late mortality is a reflection of co-morbid 
illness rather than mortality due to pneumonia. The 
low in-hospital mortality rate differs from the high 
mortality rate reported by Lerner and Federman [ l l ] .  
Four of our patients (21%) had evidence of aspira- 
tion pneumonia. We do not know how many of the 
Escherichia coli pneumonia patients had a concomitant 
urinary tract infection. Berk et a1 [12] studied 17 
patients with Escherichia coli pneumonia, all of whom 
were diagnosed on the basis of transtracheal aspirate. 
Eight of the 17 had CAP Six of the Esclzericlziu coli 
isolates had K1 antigen, and five of these six were 
community acquired. The K1 antigen, a polymer of N- 
acetyl neuraminic acid, is an Escherichia coli virulence 
factor associated with upper urinary tract infections 
Bronchopneumonia is the most common mani- 
festation of Escherichia coli pneumonia [l], but lobar 
pneumonia may occur [14-161. An occasional case 
report suggests that Escherichia coli pneumonia may 
occur in young, healthy individuals [ 161. Our data 
indicate that 10% of patients with Eschevichin coli pneu- 
monia have no co-morbidity, a figure that is similar to 
the 19% rate for pneumonia due to other etiologic 
agents. 
Our study has several limitations-we did not 
examine the urinary tract as the source of the pneu- 
monia by performing urine cultures on all our patients 
and we used sputum culture results to assign an etio- 
logic diagnosis in half the patients. Since many patients 
did not have an etiologic diagnosis, selection bias may 
have occurred. 
We conclude that Escherichia coli is the second most 
common cause of bacteremic CAP and that it is 
predominantly a disease of elderly women, many of 
whom are residents of nursing homes. 
~ 3 1 .  
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